Instrument overview
HCMHUTCHMED (China) Limited
StockNasdaqHong Kong SAR ChinaHealth careEU retail: available
−3.5% today · −9.2% over a year
No score: too little data.
No dividend.
HUTCHMED (China) Limited (HCM) belongs to the Health care sector and is listed on Nasdaq; country: Hong Kong SAR China. Over the past 12 months the price changed by −9.2%, with an annualised volatility of 38% and a largest fall of 38%. Hard red flags in our rules-based screen: Accounting red flag.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Profitability, balance-sheet safety, growth and capital discipline versus peers. More in the glossary →better than 21% of peers
Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 75% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 48% of peers
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Accrualsweighs on the score · better than 4% of peers
- Net debt / EBITDAweighs on the score · better than 12% of peers
- Return on invested capitalweighs on the score · better than 20% of peers
Red flags and notes
- Serious warning. Beneish M-score above −1.78 together with very high accruals: earnings may be overstated. More in the glossary → Beneish M-score above −1.78 together with very high accruals: earnings may be overstated.
- Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
- Caution. Net debt above 4× EBITDA or interest cover below 2×. More in the glossary → Net debt above 4× EBITDA or interest cover below 2×.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Profitability and debt
- Return on equity
- 45.7%
- Return on invested capital
- −3.4%
- Gross margin
- 38.7%
Dividends
- Dividend yield
- 0.00%
- Years of dividend growth
- 0
Returns and risk
- 1 day
- −3.5%
- 1 month
- −5.7%
- 1 year
- −9.2%
- Volatility, 1 yr
- 38.2%
- Max drawdown, 1 yr
- −37.8%
- Beta
- 0.84
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector, closest in price swings over the past year.
| 1061Essex Bio-Technology | —/10 | 5.7% | −49.7% |
|---|---|---|---|
| TEVATeva Pharmaceutical Industries Limited | 6/10 | 0.0% | 102.1% |
| ASNDAscendis Pharma A/S | 4/10 | 0.0% | 21.2% |
| 4568Daiichi Sankyo Co., Ltd. | —/10 | 3.4% | −30.7% |
| CRONCronos Group Inc. | 6/10 | 0.0% | 34.5% |
| AUPHAurinia Pharmaceuticals | —/10 | 0.0% | 37.5% |
| SRT3Sartorius AG (pref.) | —/10 | 0.3% | 24.2% |
| 4519Chugai Pharmaceutical Co., Ltd. | —/10 | 3.2% | −0.3% |
News and filings
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 27 Oct 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 26 Oct 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 21 Oct 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Sep 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Sep 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 24 Sep 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 3 Sep 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 31 Aug 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 28 Aug 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 18 Aug 2026
- HUTCHMED (China) Ltd: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 17 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.